Financial reports
10-K
2023 FY
Annual report
22 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
10-K
2022 FY
Annual report
15 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
20 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
Current reports
8-K
Changes in Registrant's Certifying Accountant
10 Apr 24
8-K
Departure of Directors or Certain Officers
9 Jun 23
8-K
Regulation FD Disclosure
6 Jun 23
8-K
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors
16 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
14 Oct 22
8-K
Departure of Directors or Certain Officers
21 Jun 22
8-K
Entry into a Material Definitive Agreement
5 Apr 22
8-K
Departure of Directors or Certain Officers
10 Mar 22
8-K
Entry into a Material Definitive Agreement
3 Dec 21
Registration and prospectus
S-1/A
IPO registration (amended)
19 Jan 23
S-1
IPO registration
17 Nov 22
DRS
Draft registration statement
29 Jul 22
F-6
Registration for ADRs (foreign)
23 Jun 21
20FR12G/A
Initial registration of securities (foreign private issuers) (amended)
1 Jun 21
20FR12G/A
Initial registration of securities (foreign private issuers) (amended)
7 May 21
20FR12G
Initial registration of securities (foreign private issuers)
12 Mar 21
Other
EFFECT
Notice of effectiveness
2 Jul 21
SEC STAFF ACTION
SEC staff action: Order
1 Jul 21
UPLOAD
Letter from SEC
7 Jun 21
CORRESP
Correspondence with SEC
28 May 21
UPLOAD
Letter from SEC
14 May 21
CORRESP
Correspondence with SEC
6 May 21
UPLOAD
Letter from SEC
3 May 21
UPLOAD
Letter from SEC
8 Apr 21
Ownership